182 related articles for article (PubMed ID: 32866111)
1. Trimethylamine-N-oxide (TMAO) predicts short- and long-term mortality and poor neurological outcome in out-of-hospital cardiac arrest patients.
Hochstrasser SR; Metzger K; Vincent AM; Becker C; Keller AKJ; Beck K; Perrig S; Tisljar K; Sutter R; Schuetz P; Bernasconi L; Neyer P; Marsch S; Hunziker S
Clin Chem Lab Med; 2020 Aug; 59(2):393-402. PubMed ID: 32866111
[TBL] [Abstract][Full Text] [Related]
2. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
[TBL] [Abstract][Full Text] [Related]
3. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.
Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042
[TBL] [Abstract][Full Text] [Related]
4. Trimethylamine N-Oxide and Mortality Risk in Patients With Peripheral Artery Disease.
Senthong V; Wang Z; Fan Y; Wu Y; Hazen SL; Tang WH
J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27792653
[TBL] [Abstract][Full Text] [Related]
5. Trimethylamine N-oxide and prognosis in acute heart failure.
Suzuki T; Heaney LM; Bhandari SS; Jones DJ; Ng LL
Heart; 2016 Jun; 102(11):841-8. PubMed ID: 26869641
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
[TBL] [Abstract][Full Text] [Related]
7. The predictive value of soluble urokinase plasminogen activator receptor (SuPAR) regarding 90-day mortality and 12-month neurological outcome in critically ill patients after out-of-hospital cardiac arrest. Data from the prospective FINNRESUSCI study.
Jalkanen V; Vaahersalo J; Pettilä V; Kurola J; Varpula T; Tiainen M; Huhtala H; Alaspää A; Hovilehto S; Kiviniemi O; Kuitunen A; Tenhunen J;
Resuscitation; 2014 Nov; 85(11):1562-7. PubMed ID: 25193800
[TBL] [Abstract][Full Text] [Related]
8. Change in neuron specific enolase levels in out-of-hospital cardiopulmonary arrest survivors as a simple and useful tool to predict neurological prognosis.
Rafecas A; Bañeras J; Sans-Roselló J; Ortiz-Pérez JT; Rueda-Sobella F; Santamarina E; Milà L; Sionis A; Gaig C; García-García C; Barrabés JA; García-Dorado D; Lidón RM
Rev Esp Cardiol (Engl Ed); 2020 Mar; 73(3):232-240. PubMed ID: 30935900
[TBL] [Abstract][Full Text] [Related]
9. Association of acyl carnitines and mortality in out-of-hospital-cardiac-arrest patients: Results of a prospective observational study.
Widmer M; Thommen EB; Becker C; Beck K; Vincent AM; Perrig S; Keller A; Bernasconi L; Neyer P; Marsch S; Pargger H; Sutter R; Tisljar K; Hunziker S
J Crit Care; 2020 Aug; 58():20-26. PubMed ID: 32279017
[TBL] [Abstract][Full Text] [Related]
10. Admission interleukin-6 is associated with post resuscitation organ dysfunction and predicts long-term neurological outcome after out-of-hospital ventricular fibrillation.
Vaahersalo J; Skrifvars MB; Pulkki K; Stridsberg M; Røsjø H; Hovilehto S; Tiainen M; Varpula T; Pettilä V; Ruokonen E;
Resuscitation; 2014 Nov; 85(11):1573-9. PubMed ID: 25238742
[TBL] [Abstract][Full Text] [Related]
11. Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI.
Matsuzawa Y; Nakahashi H; Konishi M; Sato R; Kawashima C; Kikuchi S; Akiyama E; Iwahashi N; Maejima N; Okada K; Ebina T; Hibi K; Kosuge M; Ishigami T; Tamura K; Kimura K
Sci Rep; 2019 Aug; 9(1):11647. PubMed ID: 31406181
[TBL] [Abstract][Full Text] [Related]
12. Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke.
Zhang J; Wang L; Cai J; Lei A; Liu C; Lin R; Jia L; Fu Y
J Neuroimmunol; 2021 May; 354():577526. PubMed ID: 33647820
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
Li W; Huang A; Zhu H; Liu X; Huang X; Huang Y; Cai X; Lu J; Huang Y
Med J Aust; 2020 Oct; 213(8):374-379. PubMed ID: 32959366
[TBL] [Abstract][Full Text] [Related]
14. Copeptin levels are associated with organ dysfunction and death in the intensive care unit after out-of-hospital cardiac arrest.
Ristagno G; Latini R; Plebani M; Zaninotto M; Vaahersalo J; Masson S; Tiainen M; Kurola J; Gaspari F; Milani V; Pettilä V; Skrifvars MB;
Crit Care; 2015 Mar; 19(1):132. PubMed ID: 25886856
[TBL] [Abstract][Full Text] [Related]
15. Serum neurofilament measurement improves clinical risk scores for outcome prediction after cardiac arrest: results of a prospective study.
Hunziker S; Quinto A; Ramin-Wright M; Becker C; Beck K; Vincent A; Tisljar K; Disanto G; Benkert P; Leppert D; Pargger H; Marsch S; Raoul Sutter ; Peters N; Kuhle J
Crit Care; 2021 Jan; 25(1):32. PubMed ID: 33472689
[TBL] [Abstract][Full Text] [Related]
16. Association of neuron-specific enolase values with outcomes in cardiac arrest survivors is dependent on the time of sample collection.
Vondrakova D; Kruger A; Janotka M; Malek F; Dudkova V; Neuzil P; Ostadal P
Crit Care; 2017 Jul; 21(1):172. PubMed ID: 28687073
[TBL] [Abstract][Full Text] [Related]
17. Global Registry of Acute Coronary Events risk score predicts mortality and neurological outcome in out-of hospital cardiac arrest.
Otani T; Sawano H; Natsukawa T; Matsuoka R; Morita M; Hayashi Y
Am J Emerg Med; 2017 May; 35(5):685-691. PubMed ID: 28082161
[TBL] [Abstract][Full Text] [Related]
18. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
[TBL] [Abstract][Full Text] [Related]
19. Trimethylamine N-oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction.
Zhou X; Jin M; Liu L; Yu Z; Lu X; Zhang H
ESC Heart Fail; 2020 Feb; 7(1):188-193. PubMed ID: 31960610
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
